================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------
FORM 8-K
----------
Current Report Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): May 12, 1998
PHYMATRIX CORP.
(Exact name of registrant as specified in its charter)
Delaware 0-27568 65-0617076
State or other jurisdiction of Commission File Number IRS Employer
incorporation Identification No.
Phillips Point, Suite 1000E
777 South Flagler Drive
West Palm Beach, FL 33401
(561) 655-3500
(Address and Telephone Number of Registrant's Principal Executive Offices)
================================================================================
<PAGE>
Item 5. Other Events.
On May 12, 1998, PhyMatrix Corp. issued the following statements in
a press release:
"West Palm Beach, FL -- May 12, 1998 -- PhyMatrix (Nasdaq: PHMX), a
physician-driven integrated medical management company, announced
today that its Board of Directors has instructed management to
explore various strategic alternatives for the company that could
maximize shareholder value, including possible mergers, asset sales,
management buy back, other business combinations or strategic
transactions.
Mr. Abraham D. Gosman, chairman of PhyMatrix, stated, "We strongly
believe that the market has not adequately valued our Company, and we
intend to explore a variety of transactions that may enhance
shareholder value."
There can be no assurance that the Board will conclude that any
alternative is acceptable, nor can there by any assurance that any
transaction will be completed. No timetable has been announced for
the Board or management to complete its evaluation."
* * *
<PAGE>
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PHYMATRIX CORP.
By: /s/ Frederick R. Leathers
------------------------------
Frederick R. Leathers,
Chief Financial Officer
Dated: May 22, 1998
